9:00 am

Welcome & Introductions

Steve Ornstein, MD

9:10 am

AATRIP: Overview of The 2 Year Project

Peter Miller, PhD

9:20 am

The Impact of AA-TRIP on Screening, Treatment, and BP in HTN Patients

Paul Nietert , PhD

9:40 am

Are Organizational Attributes Associated with Alcohol Screening?

Lynne Nemeth , PhD

10:00 am

Discussion: Thoughts from Practices about the Findings

Group Discussion

10:30 am

Break

10:45 am 

Strategies Used to Improve Alcohol Screening and Brief Intervention: What We Have Learned from You

Heather Liszka, MD

11:00 am

Experiences of Successful Control Practices: What Facilitates Screening and Intervention?

Ø      Plymouth Family Physicians

Ø      Advanced Health Care

11:20 am

Life after AA-TRIP: Is Routine Alcohol Screening Sustainable?  (Pros and Cons)

(Refer to Questions on page 3)

Ø      Wilson Internal Medicine

Ø      Westshore Family Medicine

11:50 am

Alcoholism Medication Survey

Attendees

12:00 pm - 1:30 pm

Lunch Break

1:30 pm

Feasibility of Alcohol Medications in Primary Care

Peter Miller, PhD

1:45 pm

Pharmacotherapy of Alcohol Dependence: 101

Andrea Wessell , PharmD

Heather Liszka, MD

Peter Miller, PhD

2:45 pm

Question and Answer Session

Attendees

3:00 pm

Break

3:10 pm

Alcohol Medication Survey

Attendees

3:15 pm

Training Your Providers Back Home: Planned Approaches; Follow-up Survey  

Peter Miller, PhD

Lynne Nemeth, PhD

3:30 pm

Barriers and Facilitators to Using Alcohol Medications

Lynne Nemeth, PhD

4:00 pm

Wrap-Up and Adjourn

Steve Ornstein, MD